Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENRICHED vs Loceryl in Onychomycosis
NCT06689852Recruiting
- Sponsor
- Oystershell
- Start
- Oct 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial in onychomycosis (2 arms), sponsored by Oystershell. Primary endpoint: Percentage of healthy nail surface at 270 days. Started Oct 2024; status: recruiting.
02
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT06689852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06689852.